O R (Israel) Buy Hold or Sell Recommendation

ORTC -- Israel Stock  

ILS 2,851  27.00  0.94%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding O R T Technologies Ltd is 'Not Rated'. Macroaxis provides O R buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding O R positions. The advice algorithm takes into account all of O R T available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from O R buy-and-hold prospective. Additionally take a look at Your Equity Center.

Time Horizon

Risk Tolerance

Execute Advice
Sell O RBuy O R
Not Rated
For the selected time horizon O R T Technologies Ltd has a risk adjusted performance of 0.105, jensen alpha of 0.0814, total risk alpha of 0.1412, sortino ratio of 0.1197 and treynor ratio of 1.68
Macroaxis provides advice on O R T Technologies Ltd to complement and cross-verify current analyst consensus on O R T. Our recommendation engine determines the company potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure O R is not overpriced, please check all O R T fundamentals including its Net Income, Cash per Share and the relationship between EBITDA and Cash and Equivalents .

O R Returns Distribution Density

Mean Return0.09Value At Risk1.1
Potential Upside1.42Standard Deviation0.96
 Return Density 

O R Alerts

Trading Alerts and Improvement Suggestions

O R T is not yet fully synchronised with the market data
O R T generates negative expected return over the last 30 days
O R T has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company reported revenue of 7.22 M. Net Loss for the year was (19.85 M) with loss before overhead, payroll, taxes, and interest of (8.52 M).
ORT TECHNOLOGIES has accumulated about 164.73 M in cash with (55.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 28.88.
On August 23, 2018 O R paid S 200.0 per share dividend to its current shareholders
Latest headline from pressoracle.com: ZIOPHARM Oncology Inc. Short Interest Up 5.8 percent in August
Additionally take a look at Your Equity Center. Please also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Search macroaxis.com